What is the value of outcomes research?
By Kevin Frick (kevin.frick@rxcomms.com) It is ironic that we should have to answer the question: “what is the value of outcomes research?” when outcomes research is a key component of…
By Kevin Frick (kevin.frick@rxcomms.com) It is ironic that we should have to answer the question: “what is the value of outcomes research?” when outcomes research is a key component of…
By Kevin Frick (kevin.frick@rxcomms.com) As we provide and interpret pharmacoeconomic (PE) evaluation results for decision makers in different settings around the world, we should consider the standards being followed. And…
Many economists think their profession has something to say about almost everything. This is because nearly everything can be thought of in terms of incentives and constraints.
Health economists interacting with colleagues and clients often need to have a global perspective, which means not limiting one’s view to what is going on in one’s own country… and that goes beyond economics.
Edited by Michael F. Drummond, Mark J. Sculpher, George W. Torrance, Bernie J. O’Brien, and Greg L. Stoddart. Oxford University Press, 2005, $55/£29.50, 379 pages. Reviewed by Kevin D. Frick…
Edited by Anne Haddix, Steven Tuesch, and Phaedra Corso, Oxford University Press, 2002, US$45, £26.99, 286 pages. Reviewed by Kevin D. Frick This text is required reading for students…
By Amy Rothman Schonfeld Print journals remain one of the most credible sources for disseminating health economic research findings, and there is consensus about which are the core publications for…